Transforming growth factor-β-induced expression of the apolipoprotein E gene requires c-Jun N-terminal kinase, p38 kinase, and casein kinase 2

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 26, Issue 6, 2006, Pages 1323-1329

  Singh, Nishi N ^a   Ramji, Dipak P ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Apolipoprotein E; Atherosclerosis; Gene expression; Macrophage; Signal transduction; TGF

Indexed keywords

APOLIPOPROTEIN E; CASEIN KINASE II; CYTOKINE; DNA; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; TRANSCRIPTION FACTOR AP 1; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; ATHEROSCLEROSIS; BINDING AFFINITY; CELL CULTURE; CELL CYCLE; CYTOKINE PRODUCTION; DNA BINDING; DOWNSTREAM PROCESSING; HUMAN; HUMAN CELL; MONOCYTIC LEUKEMIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; DOMINANT GENE; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GENETICS; MACROPHAGE; METABOLISM; MONOCYTE; PHOSPHORYLATION; PHYSIOLOGY; TUMOR CELL LINE;

APOLIPOPROTEINS E; CASEIN KINASE II; CELL LINE, TUMOR; DNA; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENES, DOMINANT; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MACROPHAGES; MONOCYTES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; TRANSCRIPTION FACTOR AP-1; TRANSFORMING GROWTH FACTOR BETA;

EID: 33745050704     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000220383.19192.55     Document Type: Article

References (32)

1. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685-1695.
2. Grainger DJ. Transforming growth factor-β and atherosclerosis: so far, so good for the protective cytokine hypothesis. Arterioscler Thromb Vasc Biol. 2004;24:399-404.
3. Panousis CG, Evans G, Zuckerman SH. TGF-β increases cholesterol efflux and ABC-1 expression in macrophage-derived foam cells: opposing the effects of IFN-γ. J Lipid Res. 2001;42:856-863.
4. Ding A, Nathan CF, Graycar J, Derynk R, Stuehr DJ, Srimal S. Macrophage deactivating factor and transforming growth factor-β1, -β2 and -β3 inhibit induction of macrophage nitric oxide synthesis by IFN-γ. J Immunol. 1990;145:940-944.
5. Edwards DR, Murphy G, Reynolds JJ, Whitman SE, Dochertt AJ, Angel P, Heath JK. Transforming growth factor-β modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J. 1987;6:1899-1904.
6. Di Febbo C, Baccante G, Reale M, Castellani ML, Angelini A, Cuccurullo F, Porreca E. Transforming growth factor β1 induces IL-1 receptor antagonist production and gene expression in rat vascular smooth muscle cells. Atherosclerosis. 1998;136:377-382.
7. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, Allen R, Sidman C, Proetzel G, Calvin D. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature. 1992;359:693-699.
8. Mallat Z, Gojova A, Marchiol-Fournigault C, Esposito B, Kamate C, Merval R, Fradelizi D, Tedgui A. Inhibition of transforming growth factor-β signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice. Circ Res. 2001;89:930-934.
9. Stefoni S, Cianciolo G, Donati G, Dormi A, Silvestri MG, Coli L, Pascalis AD, Lannelli S. Low TGF-β1 serum levels are a risk factor for atherosclerosis disease in ESRD patients. Kidney Int. 2002;61:324-335.
10. Irvine SA, Foka P, Rogers SA, Mead JR, Ramji DP. A critical role for the Sp1-binding sites in the transforming growth factor-β-mediated inhibition of lipoprotein lipase gene expression in macrophages. Nucleic Acids Res. 2005;33:1423-1434.
11. Bottalico LA, Wager RE, Agellon LB, Assoian RK, Tabas I. Transforming growth factor-β1 inhibits scavenger receptor activity in THP-1 human macrophages. J Biol Chem. 1991;266:22866-22871.
12. Draude G, Lorenz RL. TGF-β1 downregulates CD36 and scavenger receptor A but upregulates LOX-1 in human macrophages. Am J Physiol Heart Circ Physiol. 2000;278:H1042-H1048.
13. Argmann CA, Van Den Diepstraten CH, Sawyez CG, Edwards JY, Hegele RA, Wolfe BM, Huff MW. Transforming growth factor-β1 inhibits macrophage cholesteryl ester accumulation induced by native and oxidized VLDL remnants. Arterioscler Thromb Vasc Biol. 2001;21:2011-2018.
14. Greenow K, Pearce NJ, Ramji DP. The key role of apolipoprotein E in atherosclerosis. J Mol Med. 2005;83:329-342.
15. Mead JR, Hughes TR, Irvine SA, Singh NN, Ramji DP. Interferon-γ stimulates the expression of the inducible cAMP early repressor in macrophages through the activation of casein kinase 2: a potentially novel pathway for IFN-γ-mediated inhibition of gene transcription. J Biol Chem. 2003;278:17741-17751.
16. Hughes TR, Tengku-Muhammad TS, Irvine SA, Ramji DP. A novel role of Sp1 and Sp3 in the interferon-γ-mediated suppression of macrophage lipoprotein lipase gene transcription. J Biol Chem. 2002;277:1097-11106.
17. Zuckerman SH, Evans GF, O'Neal L. Cytokine regulation of macrophage apoE secretion: opposing effects of GM-CSF and TGF-β. Atherosclerosis. 1992;96:203-214.
18. Auwerx J. The human leukemia cell line, THP-1: a multifaceted model for the study of monocyte-macrophage differentiation. Experientia. 1991;47:22-31.
19. Brand K, Mackman N, Curtiss LK. Interferon-γ inhibits macrophage apolipoprotein E production by posttranslational mechanisms. J Clin Invest. 1993;91:2031-2039.
20. Castangna M. Phorbol esters as signal transducers and tumor promoters. Biol Cell. 1987;59:3-13.
21. Karin M, Liu Z, Zandi E. AP-1 function and regulation. Curr Opin Cell Biol. 1997;9:240-246.
22. 2-terminal kinase and p38 kinase in calphostin C-induced apoptosis requires caspase-3-like proteases but is dispensable for cell death. J Biol Chem. 1999;274:5310-5317.
23. Raingeaud J, Gupta S, Rogers JS, Dickens M, Han J, Ulevitch RJ, Davies RJ. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem. 1995;270:7420-7426.
24. Brown PH, Alani R, Preis LH, Szabo E, Birrer MJ. Suppression of oncogene-induced transformation by a deletion mutant of c-jun. Oncogene. 1993;8:877-876.
25. Basheeruddin K, Rechtoris C, Mazzone T. Evaluation of the role of Ap-1 like proteins in the enhanced apolipoprotein E gene transcription accompanying phorbol ester induced macrophage differentiation. Biochim Biophys Acta. 1994;1218:235-241.
26. Cavin LG, Romieu-Mourez R, Panta GR, Sun J, Factor VM, Thorgeirsson SS, Sonenshein GE, Arsura M. Inhibition of CK2 activity by TGF-β1 promotes IκB-α protein stabilization and apoptosis of immortalized hepatocytes. Hepatology. 2003;38:1540-1551.
27. Zdunek M, Silbiger S, Lei J, Neugarten J. Protein kinase CK2 mediates TGF-β1-stimulated type IV collagen gene transcription and its reversal by estradiol. Kidney Int. 2001;60:2097-2108.
28. Lebrin F, Chambaz EM, Bianchini L. A role for protein kinase CK2 in cell proliferation: evidence using a kinase-inactive mutant of CK2 catalytic subunit alpha. Oncogene. 2001;20:2010-2022.
29. Benbow U, Brinckerhoff CE. The AP-1 site and MMP gene regulation: what is all the fuss about? Matrix Biol. 1997;15:519-526.
30. Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-β family signaling. Nature. 2003;425:577-584.
31. Dhandapani KM, Hadman M, Sevilla LD, Wade MF, Mahesh VB, Brann DW. Astrocyte protection of neurons. J Biol Chem. 2003;278:43329-433339.
32. Syljuasen RG, Hong JH, McBride WH. Apoptosis and delayed expression of c-jun and c-fos after gamma irradiation of Jurkat T cells. Radiat Res. 1996;146:276-282.